Company: HCTI
Filing Date: 2025-05-23
Form Type: 8-K
Source: 0001213900-25-047425
Chunk: 0

Company: Healthcare Triangle, Inc.
Filing Date: 2025-05-23
Form: 8-K
Item: Item 3.01
Chunk 0
---
Item 3.01. Notice of Delisting or Failure to
Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On May 20, 2025, Healthcare Triangle, Inc.
(the “ Company”) received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC
(“ Nasdaq”), stating that based on its review of the Company’s public filings with the Securities and Exchange
Commission (the “ SEC”), its staff has determined to delist the Company’s securities pursuant to its discretionary
authority under Listing Rule 5101. Specifically, as set forth in the letter, Nasdaq’s staff determined that the
Company’s issuance of securities pursuant to the Company’s private placement, dated February 27, 2025, particularly the
Series A Warrants and Series B Warrants as described in the Company’s prior SEC filings, raises public interest concerns
because the application of the reset provisions contained therein can result in substantial dilution for its shareholders that may raise public interest concerns.
Accordingly, as set forth in the letter, this matter serves as an additional basis for delisting the Company’s securities from
Nasdaq.

The letter serves as a formal notification
that the Nasdaq Hearings Panel (the “ Panel”) will consider this matter in rendering a determination regarding the
Company’s continued listing on Nasdaq. The Panel has given the Company until May 30, 2025 to present its views in writing with
respect to this additional deficiency. The Company will provide the Panel with a written submission on or before May 30, 2025

The Company plans to submit a compliance plan
to the Panel. The Company also plans to apply for trading on the OTCQB market maintained by OTC Markets Group Inc. to address the risk
of delisting from Nasdaq in the event of an unfavorable Panel decision.

Forward-Looking Statements